Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Breast Cancer Topic Center

Featured Article

News
Lower Incidence of Breast Cancer Among Female Veterans Deployed During Post-9/11 Conflicts
02/02/2023
Maria Asimopoulos
Using data from more than 500,000 women treated in Veterans Affairs facilities, researchers evaluated associations between breast cancer diagnoses and history of deployment.
Using data from more than 500,000 women treated in Veterans Affairs facilities, researchers evaluated associations between breast cancer diagnoses and history of deployment.
Using data from more than...
02/02/2023
Veterans Health Today
From Veterans Health Today
Conference Coverage
Black Women More Likely to Experience Dose Delays, Worse Outcomes in Triple-Negative Breast Cancer Treatment
06/10/2022
Maria Asimopoulos
Findings presented at the 2022 ASCO Annual Meeting suggest there are disparities in care for Black women with triple-negative breast cancer as compared with White women.
Findings presented at the 2022 ASCO Annual Meeting suggest there are disparities in care for Black women with triple-negative breast cancer as compared with White women.
Findings presented at the 2022...
06/10/2022
First Report Managed Care
Conference Coverage
Symptom-Related Quality of Life in Patients Treated With First-Line Ribociclib vs Ademaciclib
06/10/2022
Maria Asimopoulos
Investigators at the 2022 ASCO Annual Meeting compared symptoms in patients receiving either ribociclib or abemaciclib in combination with endocrine therapy in the front-line setting for HR+/HER2- advanced breast cancer.
Investigators at the 2022 ASCO Annual Meeting compared symptoms in patients receiving either ribociclib or abemaciclib in combination with endocrine therapy in the front-line setting for HR+/HER2- advanced breast cancer.
Investigators at the 2022 ASCO...
06/10/2022
First Report Managed Care
Conference Coverage
Treatment Costs, Care of Patients With Metastatic Breast Cancer in the United States
06/10/2022
Samantha Matthews
Costs related to metastatic breast cancer vary by receptor subtype as well as the number of years postdiagnosis, according to research presented at the 2022 ASCO Annual Meeting.
Costs related to metastatic breast cancer vary by receptor subtype as well as the number of years postdiagnosis, according to research presented at the 2022 ASCO Annual Meeting.
Costs related to metastatic...
06/10/2022
First Report Managed Care
Conference Coverage
Assessing Alpelisib, Fulvestrant Benefit Among Patients With Advanced Breast Cancer
06/07/2022
Samantha Matthews
“Clinical benefit was maintained regardless of alterations in most biomarkers, including ESR1 and genes implicated in CDK4/6i resistance, consistent with alpelisib targeting the PIK3CA driver oncogene,” wrote researchers.
“Clinical benefit was maintained regardless of alterations in most biomarkers, including ESR1 and genes implicated in CDK4/6i resistance, consistent with alpelisib targeting the PIK3CA driver oncogene,” wrote researchers.
“Clinical benefit was maintained...
06/07/2022
First Report Managed Care
Conference Coverage
Real-World Data Suggests Palbociclib Efficacious for Treating HR+/HER2- Advanced Breast Cancer
06/06/2022
Maria Asimopoulos
A multicenter study of real-world practices in China showed palbociclib plus endocrine therapy was efficacious among patients with HR+/HER2- advanced breast cancer.
A multicenter study of real-world practices in China showed palbociclib plus endocrine therapy was efficacious among patients with HR+/HER2- advanced breast cancer.
A multicenter study of...
06/06/2022
First Report Managed Care
Conference Coverage
Effect of Ribociclib Dose Modifications on Overall Survival in Patients With HR+/HER2- Advanced Breast Cancer
06/06/2022
Samantha Matthews
Researchers at the 2022 ASCO Annual Meeting shared promising results from a trial examining the effect of dosage modifications on overall survival among postmenopausal patients with HR+/HER2- advanced breast cancer.
Researchers at the 2022 ASCO Annual Meeting shared promising results from a trial examining the effect of dosage modifications on overall survival among postmenopausal patients with HR+/HER2- advanced breast cancer.
Researchers at the 2022 ASCO...
06/06/2022
First Report Managed Care
Icario logo
Commentary
New Research to Bridge Gaps in Care for Breast Cancer Amid COVID-19
09/01/2021
Icario Team
In this commentary, the Icario team showcases engagement strategies to bridge gaps in breast cancer care after the COVID-19 pandemic reduced number of screenings and exacerbated barriers to access.
In this commentary, the Icario team showcases engagement strategies to bridge gaps in breast cancer care after the COVID-19 pandemic reduced number of screenings and exacerbated barriers to access.
In this commentary, the Icario...
09/01/2021
Population Health
From Population Health
William Audeh, MD, MS
Videos
Genomic Risk Scoring Reduces Unnecessary Chemotherapy for Breast Cancer
06/11/2021
Julie Gould
William Audeh, MD, MS, chief medical officer for Agendia, discusses the results of the MINDACT study, including how genomic risk scoring in women with breast cancer could successfully prevent unnecessary chemotherapy treatment, as well as the...
William Audeh, MD, MS, chief medical officer for Agendia, discusses the results of the MINDACT study, including how genomic risk scoring in women with breast cancer could successfully prevent unnecessary chemotherapy treatment, as well as the...
William Audeh, MD, MS, chief...
06/11/2021
First Report Managed Care
Headshot of Dr Joanne Mortimer on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Considering Patient Needs to Ensure Effective Treatments and Reduce Payer Costs
06/03/2021
Julie Gould
Joanne Mortimer, MD, director of women’s cancer programs at City of Hope, discusses the unique challenges of treating breast cancer, the importance of patient-centered treatment, and what payers can do to better accommodate patient needs...
Joanne Mortimer, MD, director of women’s cancer programs at City of Hope, discusses the unique challenges of treating breast cancer, the importance of patient-centered treatment, and what payers can do to better accommodate patient needs...
Joanne Mortimer, MD, director of...
06/03/2021
First Report Managed Care
The Critical Need for Continued Research in Breast Cancer
Podcasts
The Critical Need for Continued Research in Breast Cancer
05/06/2021
Alison Conlin, MD, MPH, medical oncologist, Providence Cancer Institute, stresses the importance of research in breast cancer care and says the stressors and outcomes of the pandemic share similarity to those of a cancer-related outcomes.
Alison Conlin, MD, MPH, medical oncologist, Providence Cancer Institute, stresses the importance of research in breast cancer care and says the stressors and outcomes of the pandemic share similarity to those of a cancer-related outcomes.
Alison Conlin, MD, MPH, medical...
05/06/2021
First Report Managed Care

Newsfeed

News
Lower Incidence of Breast Cancer Among Female Veterans Deployed During Post-9/11 Conflicts
02/02/2023
Maria Asimopoulos
Using data from more than 500,000 women treated in Veterans Affairs facilities, researchers evaluated associations between breast cancer diagnoses and history of deployment.
Using data from more than 500,000 women treated in Veterans Affairs facilities, researchers evaluated associations between breast cancer diagnoses and history of deployment.
Using data from more than...
02/02/2023
Veterans Health Today
News
Cost Consequences of IMRT After Lumpectomy
12/05/2019
The use of intensity modulated radiation therapy after lumpectomy in early-stage breast cancer is associated with roughly $8500 more in Medicare expenditures yet yields no expected major clinical benefit.
The use of intensity modulated radiation therapy after lumpectomy in early-stage breast cancer is associated with roughly $8500 more in Medicare expenditures yet yields no expected major clinical benefit.
The use of intensity modulated...
12/05/2019
First Report Managed Care
News
Breast Reconstruction Costs Lower in Hospitals With Less Competition
11/13/2019
“This suggests that some of the economies of scale, access to capital, and care delivery efficiencies gained from increased market power following hospital mergers are passed onto payers and consumers as lower costs,” researchers wrote.
“This suggests that some of the economies of scale, access to capital, and care delivery efficiencies gained from increased market power following hospital mergers are passed onto payers and consumers as lower costs,” researchers wrote.
“This suggests that some of the...
11/13/2019
First Report Managed Care
News
Financial Incentives for Cancer Screenings Yield Mixed Results
11/06/2019
“Ongoing monitoring of incentive programs is critical to determining the effectiveness of financial incentives and their effects on the improvement of cancer screening delivery rates,” researchers wrote.
“Ongoing monitoring of incentive programs is critical to determining the effectiveness of financial incentives and their effects on the improvement of cancer screening delivery rates,” researchers wrote.
“Ongoing monitoring of incentive...
11/06/2019
First Report Managed Care
News
Multigene Testing of All Women With Breast Cancer Extremely Cost-Effective
10/15/2019
Researchers recently found that unselected genetic testing of all women following breast cancer diagnosis appears highly cost-effective compared with the standard practice of testing select women based on clinical criteria or family history.
Researchers recently found that unselected genetic testing of all women following breast cancer diagnosis appears highly cost-effective compared with the standard practice of testing select women based on clinical criteria or family history.
Researchers recently found that...
10/15/2019
First Report Managed Care
News
Health Care Costs Increase With Metastatic Cancer Progression
10/09/2019
“The data obtained in our study quantify the economic value of delaying or preventing disease progression and may inform payers and physician groups about value-based payment programs,” researchers wrote.
“The data obtained in our study quantify the economic value of delaying or preventing disease progression and may inform payers and physician groups about value-based payment programs,” researchers wrote.
“The data obtained in our study...
10/09/2019
First Report Managed Care
News
HER2+ Treatment in the Era of Biosimilars, Clinical Pathways, & Precision Medicine
05/23/2018
In a Managed Care Learning Network session, Adam M Brufsky, MD, PhD, and Edward Li, PharmD, MPH, outlined the clinical and cost implications of HER2+ breast cancer treatment in the era of biosimilars, clinical pathways, and precision...
In a Managed Care Learning Network session, Adam M Brufsky, MD, PhD, and Edward Li, PharmD, MPH, outlined the clinical and cost implications of HER2+ breast cancer treatment in the era of biosimilars, clinical pathways, and precision...
In a Managed Care Learning...
05/23/2018
First Report Managed Care
News
Pfizer`s Herceptin Biosimilar Succeeds in Key Breast Cancer Study
11/30/2016
Pfizer recently announced its drug PF-05280014, biosimilar of Herceptin (trastuzumab; Roche Holding AG), met its main goal in a key study for breast cancer treatment.
Pfizer recently announced its drug PF-05280014, biosimilar of Herceptin (trastuzumab; Roche Holding AG), met its main goal in a key study for breast cancer treatment.
Pfizer recently announced its...
11/30/2016
First Report Managed Care
News
Bundled Payments for Breast Cancer Care Improve Outcomes, Controls Costs
10/25/2016
According to a study, bundled payments based on pay-for-performance for breast cancer treatment may lead to better adherence, improved outcomes, and reduced costs.
According to a study, bundled payments based on pay-for-performance for breast cancer treatment may lead to better adherence, improved outcomes, and reduced costs.
According to a study, bundled...
10/25/2016
First Report Managed Care
News
Medicare Subsidies May Help More Women Stick with Breast Cancer Drugs
10/19/2016
Recent research suggests women who are enrolled in Medicare and get subsidies to help defray the costs of drugs are more likely to continue taking therapy for breast cancer than those who do not receive financial assistance.
Recent research suggests women who are enrolled in Medicare and get subsidies to help defray the costs of drugs are more likely to continue taking therapy for breast cancer than those who do not receive financial assistance.
Recent research suggests women...
10/19/2016
First Report Managed Care
News
Rebalancing Coagulation Pathways and Human Factor 9 Gene Knock-In Strategy Identified for Hemophilia B
04/25/2024

Grace Taylor

Grace Taylor
A study published in Molecular Therapy Nucleic Acids highlights a treatment strategy for treating hemophilia B by combining rebalancing coagulation pathways and human factor 9 (hF9) gene knock-in (KI) using a lipid nanoparticle and...
A study published in Molecular Therapy Nucleic Acids highlights a treatment strategy for treating hemophilia B by combining rebalancing coagulation pathways and human factor 9 (hF9) gene knock-in (KI) using a lipid nanoparticle and...
A study published in Molecular...
04/25/2024
First Report Managed Care
News
Neurologist Recognized for Pioneering MS Research and Treatment Strategies
04/24/2024
Hannah Musick
Dr Rhonda Voskuhl received the 2024 John Dystel prize for her groundbreaking research on sex differences in multiple sclerosis (MS), advancing women's health.
Dr Rhonda Voskuhl received the 2024 John Dystel prize for her groundbreaking research on sex differences in multiple sclerosis (MS), advancing women's health.
Dr Rhonda Voskuhl received the...
04/24/2024
First Report Managed Care
News
Chicago Sky Blue May be Considered as a Diagnostic Stain for Visualizing Demodex in Patients With Demodex Blepharitis
04/24/2024
Lisa Kuhns, PhD
Chicago sky blue is a promising stain that can identify and quantify the number of Demodex mites in patients with Demodex blepharitis, according to a study published in PeerJ.
Chicago sky blue is a promising stain that can identify and quantify the number of Demodex mites in patients with Demodex blepharitis, according to a study published in PeerJ.
Chicago sky blue is a promising...
04/24/2024
First Report Managed Care
News
Adverse Events Common With Glucocorticoids for Polymyalgia Rheumatica
04/17/2024
Jolynn Tumolo
Although glucocorticoid treatment reduced inflammatory parameters in real-world patients with polymyalgia rheumatica (PMR), more than a third still showed above-normal levels throughout a 52-week follow-up period, according to study results...
Although glucocorticoid treatment reduced inflammatory parameters in real-world patients with polymyalgia rheumatica (PMR), more than a third still showed above-normal levels throughout a 52-week follow-up period, according to study results...
Although glucocorticoid...
04/17/2024
First Report Managed Care
News
Study Finds Less Bacterial Diversity in Lashes of Patients With Demodex Blepharitis
04/11/2024
Jolynn Tumolo
Bacterial diversity is decreased in the eyelashes of patients with Demodex blepharitis compared with healthy volunteers, according to a study published online in Parasites & Vectors.
Bacterial diversity is decreased in the eyelashes of patients with Demodex blepharitis compared with healthy volunteers, according to a study published online in Parasites & Vectors.
Bacterial diversity is decreased...
04/11/2024
First Report Managed Care
News
From Indolent to Aggressive: Understanding Lymphoma Transformation
04/09/2024
Hannah Musick
“Histologic transformation of indolent lymphoma to aggressive lymphoma, most commonly DLBCL, represents a well-recognized event,” said researchers. “While work in the past decade has shed light on many of the genetic and biological changes of...
“Histologic transformation of indolent lymphoma to aggressive lymphoma, most commonly DLBCL, represents a well-recognized event,” said researchers. “While work in the past decade has shed light on many of the genetic and biological changes of...
“Histologic transformation of...
04/09/2024
First Report Managed Care
News
LGBT Adults Face Higher Rates of Discrimination and Unfair Treatment in Health Care
04/05/2024
Hannah Musick
A Kaiser Family Foundation (KFF) report reveals the significant discrimination and unfair treatment faced by LGBT adults in the US, impacting mental health and access to health care, particularly for younger, lower-income, and women within...
A Kaiser Family Foundation (KFF) report reveals the significant discrimination and unfair treatment faced by LGBT adults in the US, impacting mental health and access to health care, particularly for younger, lower-income, and women within...
A Kaiser Family Foundation (KFF)...
04/05/2024
First Report Managed Care
News
Recommendations for Diagnosing and Managing Demodex Blepharitis are Presented in a New Study
04/05/2024
Lisa Kuhns, PhD
An expert panel proposed a pragmatic approach to diagnose and manage Demodex blepharitis in a recent study published in Eye.
An expert panel proposed a pragmatic approach to diagnose and manage Demodex blepharitis in a recent study published in Eye.
An expert panel proposed a...
04/05/2024
First Report Managed Care
News
Identifying Large-Vessel Vasculitis in Polymyalgia Rheumatica: Key Clinical and Laboratory Red Flags
04/05/2024
Lisa Kuhns, PhD
Potential red flags for large-vessel vasculitis in isolated polymyalgia rheumatica (PMR) include inflammatory back pain, significant pelvic involvement, widespread lower extremity pain, marked inflammatory response indicated by specific lab...
Potential red flags for large-vessel vasculitis in isolated polymyalgia rheumatica (PMR) include inflammatory back pain, significant pelvic involvement, widespread lower extremity pain, marked inflammatory response indicated by specific lab...
Potential red flags for...
04/05/2024
First Report Managed Care
News
Increased Scrutiny of Prior Authorization: Are Payers Fully to Blame, and Can AI Improve the Process?
04/05/2024
Dean Celia
The increased scrutiny of prior authorization, highlighted by media reports and government actions, prompts debate over payer responsibility while exploring the potential for AI to enhance the process.
The increased scrutiny of prior authorization, highlighted by media reports and government actions, prompts debate over payer responsibility while exploring the potential for AI to enhance the process.
The increased scrutiny of prior...
04/05/2024
First Report Managed Care

Advertisement

Insights

Icario logo
Commentary
New Research to Bridge Gaps in Care for Breast Cancer Amid COVID-19
09/01/2021
Icario Team
In this commentary, the Icario team showcases engagement strategies to bridge gaps in breast cancer care after the COVID-19 pandemic reduced number of screenings and exacerbated barriers to access.
In this commentary, the Icario team showcases engagement strategies to bridge gaps in breast cancer care after the COVID-19 pandemic reduced number of screenings and exacerbated barriers to access.
In this commentary, the Icario...
09/01/2021
Population Health
William Audeh, MD, MS
Videos
Genomic Risk Scoring Reduces Unnecessary Chemotherapy for Breast Cancer
06/11/2021
Julie Gould
William Audeh, MD, MS, chief medical officer for Agendia, discusses the results of the MINDACT study, including how genomic risk scoring in women with breast cancer could successfully prevent unnecessary chemotherapy treatment, as well as the...
William Audeh, MD, MS, chief medical officer for Agendia, discusses the results of the MINDACT study, including how genomic risk scoring in women with breast cancer could successfully prevent unnecessary chemotherapy treatment, as well as the...
William Audeh, MD, MS, chief...
06/11/2021
First Report Managed Care
Headshot of Dr Joanne Mortimer on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Considering Patient Needs to Ensure Effective Treatments and Reduce Payer Costs
06/03/2021
Julie Gould
Joanne Mortimer, MD, director of women’s cancer programs at City of Hope, discusses the unique challenges of treating breast cancer, the importance of patient-centered treatment, and what payers can do to better accommodate patient needs...
Joanne Mortimer, MD, director of women’s cancer programs at City of Hope, discusses the unique challenges of treating breast cancer, the importance of patient-centered treatment, and what payers can do to better accommodate patient needs...
Joanne Mortimer, MD, director of...
06/03/2021
First Report Managed Care
The Critical Need for Continued Research in Breast Cancer
Podcasts
The Critical Need for Continued Research in Breast Cancer
05/06/2021
Alison Conlin, MD, MPH, medical oncologist, Providence Cancer Institute, stresses the importance of research in breast cancer care and says the stressors and outcomes of the pandemic share similarity to those of a cancer-related outcomes.
Alison Conlin, MD, MPH, medical oncologist, Providence Cancer Institute, stresses the importance of research in breast cancer care and says the stressors and outcomes of the pandemic share similarity to those of a cancer-related outcomes.
Alison Conlin, MD, MPH, medical...
05/06/2021
First Report Managed Care
Common Treatment Challenges Among Patients With Breast Cancer and How it Compares to Other Cancer Types
Podcasts
Common Treatment Challenges Among Patients With Breast Cancer and How it Compares to Other Cancer Types
02/19/2021
William Rayford Gwin III, MD, medical oncologist, Seattle Cancer Care Alliance, breaks down some common challenges in treating breast cancer that make it unique compared to other types of cancer, and provides some risk reducing strategies for...
William Rayford Gwin III, MD, medical oncologist, Seattle Cancer Care Alliance, breaks down some common challenges in treating breast cancer that make it unique compared to other types of cancer, and provides some risk reducing strategies for...
William Rayford Gwin III, MD,...
02/19/2021
First Report Managed Care
Navigating Through Breast Cancer Care With the Entire Care Team and Addressing Medication Costs
Podcasts
Navigating Through Breast Cancer Care With the Entire Care Team and Addressing Medication Costs
01/07/2021
Jairam Krishnamurthy, MD, FACP, assistant professor of medicine, University of Nebraska Medical Center, reviews what it is like to navigate through breast cancer care with the whole care team—including the patient, pharmacists, other...
Jairam Krishnamurthy, MD, FACP, assistant professor of medicine, University of Nebraska Medical Center, reviews what it is like to navigate through breast cancer care with the whole care team—including the patient, pharmacists, other...
Jairam Krishnamurthy, MD, FACP,...
01/07/2021
First Report Managed Care
Identifying Risk-Reducing Strategies for Breast Cancer and How Payers Can Address the Costs of Medications
Podcasts
Identifying Risk-Reducing Strategies for Breast Cancer and How Payers Can Address the Costs of Medications
12/09/2020
Victor G Vogel, MD, medical oncologist, Geisinger Health System, discusses a variety of risk reducing strategies for breast cancer, including why some are “overdue,” explains why there is a lack in the uptake of medications among patients...
Victor G Vogel, MD, medical oncologist, Geisinger Health System, discusses a variety of risk reducing strategies for breast cancer, including why some are “overdue,” explains why there is a lack in the uptake of medications among patients...
Victor G Vogel, MD, medical...
12/09/2020
First Report Managed Care
Examining Improved Survival, Response Rates Among Patients With Breast Cancer
Podcasts
Examining Improved Survival, Response Rates Among Patients With Breast Cancer
06/24/2020
Sara Hurvitz, MD, medical oncologist, Ronald Reagan UCLA Medical Center, and Sherene Loi, PhD, senior medical oncologist, Peter MacCallum Cancer Center, discuss their recent study, HER2CLIMB, highlighting the positive findings that include...
Sara Hurvitz, MD, medical oncologist, Ronald Reagan UCLA Medical Center, and Sherene Loi, PhD, senior medical oncologist, Peter MacCallum Cancer Center, discuss their recent study, HER2CLIMB, highlighting the positive findings that include...
Sara Hurvitz, MD, medical...
06/24/2020
First Report Managed Care
Podcasts
The Relationship Between Cost, Drug Adherence Among Breast Cancer Patients
12/12/2019
In an exclusive interview at SABCS 2019, Dawn Hershman, MD, MS, professor of medicine and epidemiology at Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center, discusses how the cost of breast cancer treatment is...
In an exclusive interview at SABCS 2019, Dawn Hershman, MD, MS, professor of medicine and epidemiology at Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center, discusses how the cost of breast cancer treatment is...
In an exclusive interview at...
12/12/2019
First Report Managed Care
Podcasts
Breaking Down the Components of the Oncology Care Model
12/03/2019
“From a payer's perspective, this is a mechanism to address the dramatically rising cost of cancer care in a way that not only reduces costs, but also improves quality at the same time,” explained Charles Saunders, MD, chief executive office,...
“From a payer's perspective, this is a mechanism to address the dramatically rising cost of cancer care in a way that not only reduces costs, but also improves quality at the same time,” explained Charles Saunders, MD, chief executive office,...
“From a payer's perspective,...
12/03/2019
First Report Managed Care

Interactive Features

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 1

Current Issue

March 2024
Volume 21
Issue 1
Current Issue
Issue Archive

Advertisement

What's Trending?

Transgender Patients: Calculating the Actual Cost
09/11/2017

Dave Muoio

Dave Muoio
An unexpected announcement from President Donald Trump has propelled discussions on the costs and complications of transgender medical care into the mainstream.
An unexpected announcement from President Donald Trump has propelled discussions on the costs and complications of transgender medical care into the mainstream.
An unexpected announcement from...
09/11/2017
First Report Managed Care
News
Adverse Events Common With Glucocorticoids for Polymyalgia Rheumatica
04/17/2024
Jolynn Tumolo
Although glucocorticoid treatment reduced inflammatory parameters in real-world patients with polymyalgia rheumatica (PMR), more than a third still showed above-normal levels throughout a 52-week follow-up period, according to study results...
Although glucocorticoid treatment reduced inflammatory parameters in real-world patients with polymyalgia rheumatica (PMR), more than a third still showed above-normal levels throughout a 52-week follow-up period, according to study results...
Although glucocorticoid...
04/17/2024
First Report Managed Care
Mansur Shomali
Videos
Advancements and Challenges in Diabetes Management
02/27/2024

Featuring Mansur Shomali, MD, chief medical officer at Welldoc, endocrinologist at MedStar Health 

Featuring Mansur Shomali, MD, chief m...
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital...
02/27/2024
First Report Managed Care
Shannon Smith Headshot
Commentary
Adapting to Change: Navigating the New CMS Prior Authorization Guidelines in Health Care
04/02/2024

Shannon Smith, RN, BSN

Shannon Smith, RN, BSN
As the health care industry prepares for the Centers for Medicare & Medicaid Services (CMS) to implement new guidelines to streamline prior authorization procedures, significant operational changes are on the horizon for health care payers....
As the health care industry prepares for the Centers for Medicare & Medicaid Services (CMS) to implement new guidelines to streamline prior authorization procedures, significant operational changes are on the horizon for health care payers....
As the health care industry...
04/02/2024
First Report Managed Care
News
The Centers for Medicare and Medicaid Services has issued four new Frequently Asked Questions covering aspects of the electronic health records meaningful use program, including substantial new guidance on the Stage 2 transitions of care measures:
09/04/2013
09/04/2013
First Report Managed Care

Video Insights

William Audeh, MD, MS
Videos
Genomic Risk Scoring Reduces Unnecessary Chemotherapy for Breast Cancer
06/11/2021
Julie Gould
William Audeh, MD, MS, chief medical officer for Agendia, discusses the results of the MINDACT study, including how genomic risk scoring in women with breast cancer could successfully prevent unnecessary chemotherapy treatment, as well as the...
William Audeh, MD, MS, chief medical officer for Agendia, discusses the results of the MINDACT study, including how genomic risk scoring in women with breast cancer could successfully prevent unnecessary chemotherapy treatment, as well as the...
William Audeh, MD, MS, chief...
06/11/2021
First Report Managed Care
Tejaswi Kompala
Videos
Personalizing Weight Loss Management With GLP-1 Agonists
04/05/2024

Featuring Tejaswi Kompala, MD, head of cardiometabolic clinical strategy, Teladoc 

Featuring Tejaswi Kompala, MD, head o...
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for...
04/05/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Substance Use Disorder and Social Determinants of Health
03/27/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of...
03/27/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Suicide Prevention and Preemptive Primary Care
03/25/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first...
03/25/2024
First Report Managed Care
Yash Prajapati
Videos
Navigating the Evolution of Digital Solutions in Health Care
02/27/2024

Featuring Yash Prajapati, consultant at ZS Associates 

Featuring Yash Prajapati, consultant ...
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the...
02/27/2024
First Report Managed Care
Mansur Shomali
Videos
Advancements and Challenges in Diabetes Management
02/27/2024

Featuring Mansur Shomali, MD, chief medical officer at Welldoc, endocrinologist at MedStar Health 

Featuring Mansur Shomali, MD, chief m...
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital...
02/27/2024
First Report Managed Care
kevin cowart md
Videos
Costs and Benefits: How a New Cholesterol-Lowering Drug Compares to Others
10/24/2023

Featuring Kevin Cowart, PharmD, MPH, BCACP, CDCES

Featuring Kevin Cowart, PharmD, MPH, ...
Dr Kevin Cowart, assistant professor at the University of South Florida College of Pharmacy, discusses inclisiran, a new non-statin treatment for high cholesterol.
Dr Kevin Cowart, assistant professor at the University of South Florida College of Pharmacy, discusses inclisiran, a new non-statin treatment for high cholesterol.
Dr Kevin Cowart, assistant...
10/24/2023
First Report Managed Care
John Hennessy Headshot
Videos
Biosimilars, Explained
10/24/2023

Featuring John Hennessey, MBA

Featuring John Hennessey, MBA
In this video, John Hennessey, MBA, Valuate Health Consultancy, explains biosimilars in relation to cancer care: what they are, why they matter, and how they have and haven’t lived up to their promise.
In this video, John Hennessey, MBA, Valuate Health Consultancy, explains biosimilars in relation to cancer care: what they are, why they matter, and how they have and haven’t lived up to their promise.
In this video, John Hennessey,...
10/24/2023
First Report Managed Care
Videos
AVAHO 2023: Andrew Brunner, MD, Discusses Updates in MDS
10/20/2023

Featuring Andrew Brunner, MD

Featuring Andrew Brunner, MD
In this video, Dr Brunner reviews his recent discussion he held at the 2023 AVAHO Annual Meeting, and provides treatment updates in the treatment of MDS.
In this video, Dr Brunner reviews his recent discussion he held at the 2023 AVAHO Annual Meeting, and provides treatment updates in the treatment of MDS.
In this video, Dr Brunner...
10/20/2023
First Report Managed Care
Dr Kesty Headshot
Videos
A Dermatologist's Perspective on Demodex Blepharitis: Causes, Symptoms, and Treatment Options
10/19/2023

Featuring Katarina Kesty, MD, MBA, FAAD, Dermatologist and Medical Director at St. Petersburg Skin and Laser

Featuring Katarina Kesty, MD, MBA, FA...
Katarina Kesty, MD, MBA, FAAD, Dermatologist and Medical Director at St. Petersburg Skin and Laser, weighs in on Demodex blepharitis, a condition characterized by inflammation of the eyelid margin caused by an overpopulation of Demodex mites,...
Katarina Kesty, MD, MBA, FAAD, Dermatologist and Medical Director at St. Petersburg Skin and Laser, weighs in on Demodex blepharitis, a condition characterized by inflammation of the eyelid margin caused by an overpopulation of Demodex mites,...
Katarina Kesty, MD, MBA, FAAD,...
10/19/2023
First Report Managed Care

Advertisement

Advertisement

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement